Tscan Therapeutics, Inc. 8-K Filing
Ticker: TCRX · Form: 8-K · Filed: Nov 26, 2025 · CIK: 1783328
| Field | Detail |
|---|---|
| Company | Tscan Therapeutics, Inc. (TCRX) |
| Form Type | 8-K |
| Filed Date | Nov 26, 2025 |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $399,000, $170,000, $250,000 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Tscan Therapeutics, Inc. (ticker: TCRX) to the SEC on Nov 26, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (which registered Voting Common Stock, $0.0001 par value per share TCRX The Nasdaq); $399,000 (. Louis will receive (i) cash awards of $399,000, $170,000 and $250,000, respectively, w); $170,000 (ll receive (i) cash awards of $399,000, $170,000 and $250,000, respectively, with 50% of); $250,000 () cash awards of $399,000, $170,000 and $250,000, respectively, with 50% of the cash awa).
How long is this filing?
Tscan Therapeutics, Inc.'s 8-K filing is 3 pages with approximately 904 words. Estimated reading time is 4 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 904 words · 4 min read · ~3 pages · Grade level 13.4 · Accepted 2025-11-26 16:15:12
Key Financial Figures
- $0.0001 — which registered Voting Common Stock, $0.0001 par value per share TCRX The Nasdaq
- $399,000 — . Louis will receive (i) cash awards of $399,000, $170,000 and $250,000, respectively, w
- $170,000 — ll receive (i) cash awards of $399,000, $170,000 and $250,000, respectively, with 50% of
- $250,000 — ) cash awards of $399,000, $170,000 and $250,000, respectively, with 50% of the cash awa
Filing Documents
- d41366d8k.htm (8-K) — 26KB
- 0001193125-25-300538.txt ( ) — 139KB
- tcrx-20251125.xsd (EX-101.SCH) — 3KB
- tcrx-20251125_lab.xml (EX-101.LAB) — 18KB
- tcrx-20251125_pre.xml (EX-101.PRE) — 11KB
- d41366d8k_htm.xml (XML) — 4KB
Forward-Looking Statements
Forward-Looking Statements This Current Report on Form 8-K contains forward-looking statements that are based on the Company's beliefs and assumptions and on information currently available to the Company on the date of this Current Report. These forward-looking statements involve substantial risks and uncertainties. Any statements in this Current Report on Form 8-K other than statements of historical fact, including statements about the Company's future expectations, plans and prospects, constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, express or implied statements regarding expectations, hopes, beliefs, intentions or strategies of the Company regarding the Retention Program, and any other statements containing the words "anticipate," "believe," "estimate," "expect," "intend", "goal," "may", "might," "plan," "predict," "project," "seek," "target," "potential," "will," "would," "could," "should," "continue," and similar expressions. Such forward-looking statements involve substantial risks and uncertainties that could cause the Company's financial and operating results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements, including the factors discussed in the "Risk Factors" section contained in the quarterly and annual reports that the Company files with the Securities and Exchange Commission. Any forward-looking statements represent the Company's views only as of the date of this Current Report on Form 8-K. The Company anticipates that subsequent events and developments may cause its views to change. While the Company may elect to update these forward looking statements at some point in the future, the Company specifically disclaims any obligation to do so except as required by law even if new information becomes available in the future. SIGNATUR